Novavax Inc on Monday said its COVID-19 vaccine was more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based clinical trial. The study of nearly 30,000 volunteers in the United States and Mexico puts Novavax on track to file for emergency …
Read More »Novavax awarded $1.6 billion for coronavirus vaccine
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization, and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021. Novavax shares jumped 35% in premarket trade. The award is the biggest yet from “Operation …
Read More »